当前位置: 首页 > 期刊 > 《中国医药导报》 > 2011年第33期
编号:1606215
关于加强国家基本药物制度监管的探讨
http://www.100md.com 2012年1月9日 中国医药导报 2011年第33期
实施现状,存在问题
     莫文娟 笪远锋

    [摘要] 国家基本药物制度自启动实施以来,已取得了明显进展,对促进我国医药事业的健康发展、规范药品管理、实施临床合理用药产生了深远影响,但也出现了一些问题,如基本药物的集中招标采购不够规范,没能有效合理地解决药品价格虚高问题,甚至一些地区产生了药品断供、缺货等新的问题,对基本药物制度的实施效果产生了影响,同时也对群众的受益程度产生了影响。本文将结合我国国情,从药品监督管理部门的角度就如何推动我国基本药物制度展开讨论。

    [关键词] 基本药物制度;实施现状;存在问题;监管

    [中图分类号] C913.7 [文献标识码] C[文章编号]1673-7210(2011)11(c)-142-02

    Investigation on the supervision of national essential drug system

    MO Wenjuan1, DA Yuanfeng2

    1.Drug Supervision and Inspection Institute of Kunshan City, Jiangsu Province, Kunshang 215300, China; 2.Jiangsu Farmtec Research Co., Ltd., Jiangsu Province, Kunshan 215300, China

    [Abstract] National essential drug system has achieved considerable progress since implementation. It has the profound influence on promoting health development of China medicine careers, regulating medicine management and implementing clinical rational drug use, but it also appears some problems such as essential drug pooled-procurement is irregular and the solution of virtual-high medicine price is ineffective, even new problems of drug outages and stockout has occurred in some place. These problems affect the implementation effect of essential drug system and the benefit degree of masses. According to our national's conditions, this article discusses how to promote the national essential drug system from the angle of supervision administrative department. ......

您现在查看是摘要页,全文长 8088 字符